NYSE: BMYBristol Myers Squibb Co Stock Ownership
Insider buying vs selling
Have Bristol Myers Squibb Co insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Giovanni Caforio | Board Chair and CEO | 2021-09-20 | 25,000 | $60.64 | $1.52MSell |
| David V. Elkins | EVP Chief Financial Officer | 2021-08-12 | 6,180 | $48.49 | $299.67kBuy |
| David V. Elkins | EVP Chief Financial Officer | 2021-08-12 | 59,691 | $48.49 | $2.89MBuy |
| David V. Elkins | EVP Chief Financial Officer | 2021-08-12 | 4,129 | $48.49 | $200.22kBuy |
| David V. Elkins | EVP Chief Financial Officer | 2021-08-12 | 59,691 | $67.00 | $4.00MSell |
| David V. Elkins | EVP Chief Financial Officer | 2021-08-12 | 40,000 | $66.88 | $2.68MSell |
| Ann Powell | EVP Chief Human Resources | 2021-08-03 | 23,280 | $68.57 | $1.60MSell |
| Giovanni Caforio | Chairman and CEO | 2021-08-02 | 20,000 | $68.58 | $1.37MSell |
| David V. Elkins | EVP Chief Financial Officer | 2021-08-01 | 23,736 | $67.87 | $1.61MSell |
| Rupert Vessey | EVP Research & Early Dev. | 2021-07-30 | 17,630 | $56.44 | $995.04kBuy |
BMY insiders have sold more BMY shares than they have bought in the last year
Ownership
BMY Shareholders
What type of owners hold Bristol Myers Squibb Co stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Vanguard Group Inc | 8.88% | 197,341,430 | $11.52B | Institution |
| Blackrock Inc | 7.88% | 175,100,707 | $10.22B | Institution |
| State Street Corp | 4.15% | 92,145,348 | $5.38B | Institution |
| Jpmorgan Chase Co | 3.75% | 83,298,152 | $4.86B | Institution |
| Fmr LLC | 3.08% | 68,475,862 | $4.00B | Institution |
| Wellington Management Group Llp | 1.98% | 43,963,060 | $2.57B | Institution |
| Geode Capital Management LLC | 1.62% | 35,957,818 | $2.10B | Institution |
| Ameriprise Financial Inc | 1.36% | 30,215,938 | $1.76B | Institution |
| Bank Of America Corp | 1.29% | 28,607,490 | $1.67B | Institution |
| Dodge Cox | 1.28% | 28,473,658 | $1.66B | Institution |
Bristol Myers Squibb Stock Ownership FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.